|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.380 EUR | -1.17% |
|
-1.72% | +28.57% |
| 07-14 | Ironwood Pharmaceuticals, Inc. Announces Management Changes | CI |
| 05-27 | Ironwood Says US FDA Approves Linzess Use in Children Aged Two Years and Older With Functional Constipation | MT |
| Market Cap | 639M 560M 520M 477M 900M 61.63B 913M 6.19B 2.42B 30.16B 2.4B 2.35B 104B | P/E 2026 * |
3.27x | P/E 2027 * | 3.14x |
|---|---|---|---|---|---|
| Enterprise Value | 639M 560M 520M 477M 900M 61.63B 913M 6.19B 2.42B 30.16B 2.4B 2.35B 104B | EV / Sales 2026 * |
1.39x | EV / Sales 2027 * | 1.34x |
| Free-Float |
96.84% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Ironwood Pharmaceuticals, Inc.
| 1 week | -1.72% | ||
| Current month | -6.56% | ||
| 1 month | +3.01% | ||
| 3 months | -2.84% | ||
| 6 months | -24.67% | ||
| Current year | +28.57% |
| 1 week | 3.2 |  | 3.48 |
| 1 month | 3.2 | | 4.24 |
| 3 years | 0.48 | | 14.5 |
| 5 years | 0.48 | | 14.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas McCourt
CEO | Chief Executive Officer | 68 | 2021-03-11 |
Ronald Silver
DFI | Director of Finance/CFO | 44 | 2026-05-14 |
Jeffrey Silber
CTO | Chief Tech/Sci/R&D Officer | - | 2026-07-19 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas McCourt
BRD | Director/Board Member | 68 | 2021-06-03 |
Julie McHugh
CHM | Chairman | 61 | 2019-03-31 |
Marla Kessler
BRD | Director/Board Member | 56 | 2019-03-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.17% | -1.72% | +414.29% | -64.19% | 639M | |
| +0.96% | +3.12% | +56.19% | +15.47% | 315B | |
| -0.86% | -1.41% | +21.10% | -13.68% | 67.93B | |
| -0.99% | +2.64% | +35.25% | +81.44% | 9.23B | |
| -1.26% | -1.95% | +2.83% | -4.98% | 8.43B | |
| -1.03% | -1.79% | -24.11% | -10.07% | 4.07B | |
| +0.38% | -9.58% | -5.58% | +22.13% | 3.77B | |
| +0.86% | +1.01% | -43.84% | +10.01% | 3.54B | |
| -1.94% | -1.66% | +43.68% | +53.35% | 2.72B | |
| -2.81% | -6.33% | +5.13% | -9.94% | 2.13B | |
| Average | -0.76% | -0.91% | +50.49% | +7.95% | 46.3B | |
| Weighted average by Cap. | +0.49% | +3.04% | +46.95% | +11.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 460M 403M 374M 344M 648M 44.4B 658M 4.46B 1.75B 21.73B 1.73B 1.69B 75.05B | 478M 419M 389M 358M 674M 46.16B 684M 4.64B 1.81B 22.59B 1.8B 1.76B 78.02B |
| Net income | 182M 159M 148M 136M 256M 17.52B 260M 1.76B 689M 8.57B 682M 667M 29.62B | 210M 184M 171M 157M 296M 20.25B 300M 2.03B 796M 9.91B 788M 771M 34.23B |
| Net Debt | - | - |
| Date | Price | Change |
|---|---|---|
| 26-07-23 | €3.320 | -2.92% |
| 26-07-22 | €3.420 | 0.00% |
| 26-07-21 | €3.420 | +1.79% |
| 26-07-20 | €3.360 | -0.59% |
| 26-07-17 | €3.380 | +0.60% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IRWD Stock
- I76 Stock
Select your edition
All financial news and data tailored to specific country editions
